U.S. CDC Advisory Committee recommended use of Valneva’s single-dose Chikungunya caccine IXCHIQ
On Feb. 29, 2024, Valneva announced that the U.S. Centers for Disease Control and Preventionﾒs (CDC) Advisory Committee…
-
-
FDA and industry actions end sales of Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) used in U.S. food packaging
On Feb. 28, 2024, the U.S. Food and Drug Administration (FDA) announced that grease-proofing materials containing per- and…
-
CDC | COVID-19 | Therapeutics | Vaccine
CDC Advisory Committee recommended older adults able to receive additional dose of updated COVID-19 vaccine
On Feb. 28, 2024, the CDC Advisory Committee on Immunization Practices’ (ACIP) announced a recommendation for adults ages…
-
Novavax’s protein-based non-mRNA COVID-19 vaccine available as additional dose for individuals aged 65 and older
On Feb. 28, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
-
C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
On Feb. 24, 2024, C2N Diagnostics (C2N) announced the medical device registration from the United Kingdom’s Medicines and…
-
Biotechnology | Clinical Research | Disease | Medicine | Neurology | Oncology | Stem Cell | Therapeutics
California’s Stem Cell Agency awarded $56 million for clinical research, $21.3 million for Shared Labs program
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative…
-
First Tissue Bank May Help Solve Mystery of Long COVID Misery
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
-
Scientists developed a simple blood test to quickly diagnose sarcoidosis
On Feb. 22, 2024, a National Institutes of Health (NIH) research supported project announced development of a tool…
-
NIH launched research network to evaluate emerging cancer screening technologies
On Feb. 21, 2024, the National Institutes of Health (NIH) announced it had launched a clinical trials network…
-
CPRIT approved almost $100 million in grants to advance the fight against cancer in Texas
On Feb. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
-
Fred Hutch to lead new federal Cancer Screening Research Network
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
-
USDA and University of Georgia broke ground on new agriculture research facility in Tifton, Georgia
On Feb. 21, 2024, the U.S. Department of Agriculture (USDA) and the University of Georgia (UGA) College of…
-
COVID-19 | Life Science History | Measles | Vaccine | WHO
WHO reported more than half the world faces high measles risk
On Feb. 21, 2024, the World Health Organization (WHO) reported that more than half the world’s countries will…
-
USDA confirmed highly pathogenic avian influenza in backyard non-poultry flock in West Virginia
On Feb. 20, 2024, the U.S. Department of Agriculture (USDA) confirmed the presence of highly pathogenic avian influenza…
-
275 million new genetic variants identified in National Institutes of Health precision medicine data
On Feb. 19, 2024, the National Institutes of Health (NIH) announced that researchers had discovered more than 275…
-
Japan first in the world to approve Dupixent (dupilumab) for chronic spontaneous urticaria
On Feb. 16, 2024, Regeneron and Sanofi announced that the Ministry of Health, Labor and Welfare (MHLW) in…
-
Agriculture | Biotechnology | CDC | Medicine
U.S. Centers for Disease Control and Prevention warned of E. Coli outbreak linked to raw milk cheese
On Feb. 16, 2024, the U.S. Centers for Disease Control and Prevention announced that ten people infected with…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approved Xolair as first and only medicine for children and adults with one or more food allergies
On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…
-
Australian government approved release of QUT-developed GM Cavendish QCAV-4
On Feb. 16, 2024, the Australian Government announced it had issued QUT a licence to commercially release QCAV-4,…
-
New biosecurity group aims to prevent biotech disasters
On Feb. 15, 2024, Biosecurity experts today launched a new international nonprofit designed to prevent modern biotechnology from…
-
COVID-19 vaccination and boosting during pregnancy protects infants for six months
On Feb. 14, 2024, the National Institute of Allergy and Infectious Diseases (NIAID) reported study results that showed…
-
FDA approved first medication to treat severe frostbite
On Feb. 14, 2024, the U.S. Food and Drug Administration (FDA) approved Eicos Sciences’ Aurlumyn (iloprost) injection to…
-
European Commission approved first CRISPR/Cas9 gene-edited therapy, CASGEVY for reatment of SCD and TDT
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
-
First human influenza A(H5N1) (bird flu)virus infections in Cambodia reported for 2024
On Feb. 12, 2024, the U.S. Centers for Disease Control and Prevention (CDC) announced that Cambodia had reported…
-
Alaska Department of Health confirmed first fatal case of Alaskapox virus
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
-
National Science Foundation invested nearly $10 million to develop transformative bio-inspired solutions
On Feb. 8, 2024, the National Science Foundation (NSF) announced it was investing $9.75 million to advance novel…
-
Deschutes County confirmed case of human plague in local resident
On Feb. 8, 2024, Deschutes County Health Services in Bend, Oregon confirmed a case of human plague in…
-
USDA provided more than $70 Million to protect food supply and natural resources from invasive pests and diseases
On Feb. 6, 2024, the U.S. Department of Agriculture (USDA) announced it was investing over $70 million in…
-
Switching arms improved effectiveness of two-dose vaccinations, Oregon Health & Science University study suggested
On Feb. 6, 2024, Oregon Health & Science University (OHSU) announced research that revealed as much as a…
-
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrated Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
On Feb. 5, 2024, CSL and and Arcturus Therapeutics announced the results of a follow-up analysis of a…
